These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6391407)

  • 1. Theophylline in stable chronic airflow obstruction. A reappraisal.
    Dull WL; Alexander MR
    Arch Intern Med; 1984 Dec; 144(12):2399-401. PubMed ID: 6391407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eaton ML; MacDonald FM; Church TR; Niewoehner DE
    Chest; 1982 Nov; 82(5):538-42. PubMed ID: 7128220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities for optimizing therapy with theophylline preparations. Clinical effectiveness and side effects of microcrystalline theophylline].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):11-7. PubMed ID: 6426180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
    Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
    Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease.
    Dull WL; Alexander MR; Sadoul P; Woolson RF
    Am Rev Respir Dis; 1982 Oct; 126(4):656-9. PubMed ID: 6751178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practicability, effectiveness and tolerance of a standardized prepared theophylline infusion].
    Pohl WR; Kummer F; Lorber H; Würtz J; Aigner K; Pfeiffer KP
    Acta Med Austriaca; 1996; 23(3):105-8. PubMed ID: 8967286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator response in chronic obstructive pulmonary disease.
    Anthonisen NR; Wright EC
    Am Rev Respir Dis; 1986 May; 133(5):814-9. PubMed ID: 3706890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline.
    Tsukagoshi H; Shimizu Y; Iwamae S; Hisada T; Ishizuka T; Iizuka K; Dobashi K; Mori M
    Respir Med; 2000 Jun; 94(6):584-8. PubMed ID: 10921764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
    Dai L; Li X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
    Thomas P; Pugsley JA; Stewart JH
    Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions of theophylline and nifedipine].
    Luther R; Wichert H; Köhler E; Banditt P; Walther H
    Z Erkr Atmungsorgane; 1990; 174(2):97-103. PubMed ID: 2349818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter study with a large number of patients for the validation of pharmacokinetic and clinical findings from controlled studies with small patient cohorts].
    Götz JK; Sauter R
    Pneumologie; 1991 Nov; 45 Suppl 4():867-74. PubMed ID: 1812482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation.
    Guyatt GH; Townsend M; Nogradi S; Pugsley SO; Keller JL; Newhouse MT
    Arch Intern Med; 1988 Sep; 148(9):1949-52. PubMed ID: 3046537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Euphylong in patients with chronic obstructive airway diseases].
    Kublik A; von Wichert P
    Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
    Bleecker ER; Britt EJ
    Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.